Zou, Jifeng Ginsenoside Rg3 suppresses the growth of gemcitabine-resistant pancreatic cancer cells by upregulating lncRNA-CASC2 and activating PTEN signaling. [electronic resource] - Journal of biochemical and molecular toxicology Jun 2020 - e22480 p. digital Publication Type: Journal Article ISSN: 1099-0461 Standard No.: 10.1002/jbt.22480 doi Subjects--Topical Terms: AnimalsAntineoplastic Agents, Phytogenic--pharmacologyApoptosis--drug effectsCell Line, TumorCell Proliferation--drug effectsCell Survival--drug effectsDeoxycytidine--analogs & derivativesDrug Resistance, Neoplasm--drug effectsGinsenosides--pharmacologyHumansMiceMice, Inbred BALB CMice, NudePTEN Phosphohydrolase--metabolismPancreatic Neoplasms--drug therapySignal Transduction--drug effectsTransfectionTumor Burden--drug effectsTumor Suppressor Proteins--geneticsUp-Regulation--drug effectsXenograft Model Antitumor AssaysGemcitabine